ArticleCancer immunology research2014

Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies.

Gregory L Beatty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.